Taysha Gene Therapies, Inc. (TSHA) Ownership

$2.71

$0.04 (-1.46%)
Last update: 04:00 PM EST
Day's range
$2.67
Day's range
$2.74

Taysha Gene Therapies, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
AVORO CAPITAL ADVISORS LLC 05/15/2025 20.00 M $27.80 M   0.00% 8.00%
RTW INVESTMENTS, LP 05/15/2025 18.79 M $26.12 M   116.63% 7.51%
MORGAN STANLEY 05/15/2025 16.85 M $23.42 M   -4.50% 6.26%
FMR LLC 05/12/2025 15.63 M $21.73 M   -4.48% 5.80%
BLACKROCK, INC. 05/02/2025 13.59 M $18.89 M   0.43% 5.05%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 10.87 M $15.11 M   0.00% 4.35%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 10.70 M $14.87 M   2.39% 3.97%
VANGUARD GROUP INC 05/09/2025 8.77 M $12.19 M   -1.53% 3.26%
SIREN, L.L.C. 05/23/2025 6.51 M $9.06 M   -1.33% 2.42%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 4.57 M $6.35 M   100.00% 1.70%
BAKER BROS. ADVISORS LP 05/15/2025 4.00 M $5.57 M   0.00% 1.60%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 05/15/2025 3.70 M $5.14 B   0.00% 1.37%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.66 M $5.10 M   2.59% 1.36%
STATE STREET CORP 05/15/2025 3.23 M $4.49 M   -50.06% 1.20%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 3.00 M $4.17 M   0.00% 1.11%
MILLENNIUM MANAGEMENT LLC 05/15/2025 1.77 M $2.46 M   1,069.19% 0.71%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2025 1.64 M $2.28 M   0.27% 0.66%
PALO ALTO INVESTORS LP 05/15/2025 1.42 M $1.97 M   74.97% 0.57%
NORTHERN TRUST CORP 05/13/2025 1.43 M $1.99 M   -1.86% 0.53%
05/15/2025 1.26 M $1.75 M   30.03% 0.50%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 1.07 M $1.48 M   500.04% 0.43%
JPMORGAN CHASE & CO 05/12/2025 1.00 M $1.39 M   -62.06% 0.37%
WOODLINE PARTNERS LP 05/15/2025 858.25 K $1.19 M   -16.47% 0.32%
QUANTUM PRIVATE WEALTH, LLC 05/13/2025 791.48 K $1.10 M   -0.44% 0.29%
SUPERSTRING CAPITAL MANAGEMENT LP 05/15/2025 755.60 K $1.05 M   100.00% 0.28%
SANDS CAPITAL VENTURES, LLC 05/14/2025 724.87 K $1.01 M   0.00% 0.27%
BARCLAYS PLC 05/15/2025 708.97 K $985.00 K   111.48% 0.26%
ALPHABET INC. 05/02/2025 640.88 K $890.83 K   0.00% 0.24%
BANK OF AMERICA CORP /DE/ 05/15/2025 636.84 K $885.21 K   -62.76% 0.24%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 625.20 K $869.03 K   6.76% 0.23%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 522.50 K $726.28 K   0.00% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 547.13 K $760.51 K   15.37% 0.20%
05/12/2025 546.41 K $759.52 K   100.00% 0.20%
BANK OF NEW YORK MELLON CORP 04/29/2025 453.42 K $630.25 K   0.70% 0.17%
GOLDMAN SACHS GROUP INC 05/16/2025 359.01 K $499.02 K   -62.88% 0.13%
KOVITZ INVESTMENT GROUP PARTNERS, LLC 05/19/2025 292.78 K $406.96 K   100.00% 0.11%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 245.25 K $340.90 K   100.00% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 227.47 K $316.19 K   59.67% 0.08%
CITADEL ADVISORS LLC 05/15/2025 216.61 K $301.09 K   -70.93% 0.08%
RHUMBLINE ADVISERS 05/29/2025 205.46 K $285.58 K   6.97% 0.08%
XTX TOPCO LTD 05/08/2025 203.13 K $282.35 K   100.00% 0.08%
INVESCO LTD. 05/12/2025 159.90 K $222.26 K   83.05% 0.06%
LOS ANGELES CAPITAL MANAGEMENT LLC 05/05/2025 142.81 K $198.51 K   3.89% 0.05%
HRT FINANCIAL LP 05/15/2025 139.69 K $194.00 K   100.00% 0.05%
ENTRYPOINT CAPITAL, LLC 05/14/2025 135.90 K $188.90 K   120.99% 0.05%
PRIVIUM FUND MANAGEMENT B.V. 05/09/2025 134.90 K $187.51 K   0.00% 0.05%
DEUTSCHE BANK AG\ 05/09/2025 134.42 K $186.84 K   -11.03% 0.05%
CITIGROUP INC 05/12/2025 133.19 K $185.14 K   -47.41% 0.05%
05/09/2025 117.06 K $162.72 K   100.00% 0.04%
CHICAGO PARTNERS INVESTMENT GROUP LLC 05/09/2025 116.57 K $221.47 K   0.45% 0.04%

Taysha Gene Therapies, Inc. institutional Ownership - FAQ's

During the previous two years, 145 institutional investors and hedge funds held shares of Taysha Gene Therapies, Inc.. The most heavily invested institutionals were:

Avoro Capital Advisors LLC: 20 M

RTW INVESTMENTS, LP: 18.79 M

MORGAN STANLEY: 16.85 M

FMR LLC: 15.63 M

BlackRock, Inc.: 13.59 M

RA CAPITAL MANAGEMENT, L.P.: 10.87 M

61.92% of Taysha Gene Therapies, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 180.24 M shares in the last 24 months. This purchase volume represents approximately $488.44 M in transactions.